The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kenis V.M.

The Turner Scientific Research Institute for Children’s Orthopedics, Saint-Petersburg, Russia

Baindurashvili A.G.

Turner Research Institute for Pediatric Orthopedics, Health Ministry of the Russian Federation, St. Petersburg, Russia

Dovbeshko A.G.

Korol'kova T.N.

Sankt-Peterburg Academy of Advanced Medical Training

Ivanov A.M.

FGBVOU VPO «Voenno-meditsinskaja akademija im. S.M. Kirova» MO RF, 194044 Sankt-Peterburg, ul. Akademika Lebedeva, 6

Stepanova Yu.A.

A.V. Vishnevsky Institute of Surgery, Ministry of Health of the Russian Federation, Moscow

Protasov O.V.

Botulinum toxine treatment and the formation of antibodies to botulotoxin in patients with cerebral palsy

Authors:

Kenis V.M., Baindurashvili A.G., Dovbeshko A.G., Korol'kova T.N., Ivanov A.M., Stepanova Yu.A., Protasov O.V.

More about the authors

Read: 2727 times


To cite this article:

Kenis VM, Baindurashvili AG, Dovbeshko AG, Korol'kova TN, Ivanov AM, Stepanova YuA, Protasov OV. Botulinum toxine treatment and the formation of antibodies to botulotoxin in patients with cerebral palsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(9):48‑51. (In Russ.)

Recommended articles:
Expe­rience of Rela­tox (botulinum toxin type A) using for chro­nic migraine treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):134-140
Complex balneotherapy at the stage of spa treatment of children with cere­bral palsy. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):29-37
Modern concepts of the blood supply to the frontalis muscle: anatomy, clinical aspe­cts, and significance. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(4):60-67

References:

  1. Kenis V.M. Primenenie botulotoksinov v kompleksnom lechenii detei s DTsP. Materialy XI Rossiiskogo natsional'nogo kongressa "Chelovek i ego zdorov'e". (Sankt-Peterburg, 23 noyabrya 2006 g.). Sbornik "Chelovek i zdorov'e". St-Peterburg 2006.
  2. Klimenko V.A. Dvigatel'nye narusheniya i soputstvuyushchie sindromy u detei s tserebral'nymi paralichami, ikh korrektsiya i profilaktika v usloviyakh ortopedicheskogo statsionara: Avtoref. dis. … d-ra med. nauk. St-Peterburg 1993; 78.
  3. Umnov V.V., Kenis V.M. Sovremennye podkhody k lecheniyu lokal'noi spastichnosti u detei s tserebral'nym paralichom. Materialy nauchno-prakticheskoi konferentsii detskikh travmatologov-ortopedov Rossii (19-21 sentyabrya 2007). Ekaterinburg 2007; 282-284.
  4. Boyd R., Graham H.K. Botulinum toxin A in the management of children with cerebral palsy: indications and outcome. Eur J Neurol 1997; 4: 15-22.
  5. Dressler D., Bigalke H. Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy. Movement Disorders 2002; 17: 170-173.
  6. Herrmann J., Geth K., Mall V. et al. Clinical impact of antibody formation to botulinum toxin A in children. Annals of Neurology 2004; 55: 732-735.
  7. Koman L.A., Mooney J.F., Smith B.P. et al. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediat Orthoped 1994; 14: 299-303.
  8. Lange O., Bigalke H., Dengler R. et al. Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol 2009; 32: 4: 213-218.
  9. Lawrence I., Moy R. An Evaluation of Neutralizing Antibody Induction During Treatment of Glabellar Lines with a New US Formulation of Botulinum Neurotoxin Type A. Aesthetic Surgery J 2009; 29: 6: 66-71.
  10. Lee S.K. Antibody-Induced Failure of Botulinum Toxin Type A Therapy in a Patient with Masseteric Hypertrophy. Dermatologic Surgery 2007; 33: 105-110.
  11. Saraph V., Zwick E.B., Steinwender C. et al. Conservative management of dynamic equinus in diplegic children treated by gait improvement surgery. J Pediatr Orthop 2001; 10: 287-292.
  12. Smith M.E., Ford C.N. Resistance to Botulinum Toxin Injections for Spasmodic Dysphonia. Arch Otolaryngol Head Neck Surg 2000; 126: 533-535.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.